eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Listing of Approved Drug Products Containing Dronabinol in Schedule III
Listing of Approved Drug Products Containing Dronabinol in Schedule III
Document ID:
DEA-2010-0023-0001
Document Type:
Proposed Rule
Agency:
Drug Enforcement Administration
Topics:
Administrative Practices and Procedures, Drug Traffic Control, Narcotics, Prescription Drugs
CFR Citation:
21 CFR Part 1308
View Document:
Details Information
Document Subtype:
NPRM
Received Date:
November 01 2010, at 12:00 AM Eastern Daylight Time
Start-End Page:
67054 - 67059
Comment Start Date:
November 1 2010, at 12:00 AM Eastern Standard Time
Comment Due Date:
January 3 2011, at 11:59 PM Eastern Standard Time
Comments
View All
Total:
13
Adkins_DEA 344
Submitter:
Adkins, Sarah
Posted:
11/08/2010
ID:
DEA-2010-0023-0006
Comment Period Closed
Jan 03,2011 11:59 PM ET
Schoeffler_DEA 344
Submitter:
Schoeffler, Linda
Posted:
11/16/2010
ID:
DEA-2010-0023-0007
Comment Period Closed
Jan 03,2011 11:59 PM ET
Mitteer_DEA 344
Submitter:
MITTEER, MARK
Posted:
11/16/2010
ID:
DEA-2010-0023-0008
Comment Period Closed
Jan 03,2011 11:59 PM ET
Rakoczy_DEA 344
Submitter:
Rakoczy, William
Posted:
12/02/2010
ID:
DEA-2010-0023-0009
Comment Period Closed
Jan 03,2011 11:59 PM ET
Nexus_DEA 344
Submitter:
Nexus, Lyme
Posted:
12/02/2010
ID:
DEA-2010-0023-0010
Comment Period Closed
Jan 03,2011 11:59 PM ET
Related Documents
More
Total:
32
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids into Schedule I
Schedules of Controlled Substances: Placement of Lorcaserin into Schedule IV
Schedules of Controlled Substances: Placement of Methylone into Schedule I
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids Into Schedule I
Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV
Establishment of Drug Codes for 26 Substances
Schedules of Controlled Substances: Placement of Lorcaserin into Schedule IV
Schedules of Controlled Substances: Extension of Temporary Placement of Methylone Into Schedule I
Schedules of Controlled Substances: Placement of Methylone into Schedule I
Schedules of Controlled Substances: Placement of Five Synthetic Cannabinoids into Schedule I
Schedules of Controlled Substances: Extension of Temporary Placement of Five Synthetic Cannabinoids Into Schedule I of the Controlled Substances Act
Schedules of Controlled Substances: Placement of Ezogabine Into Schedule V
Schedules of Controlled Substances: Placement of Carisoprodol Into Schedule IV
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cathinones Into Schedule I
Schedules of Controlled Substances: Placement of Ezogabine into Schedule V
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cathinones Into Schedule I
Establishment of a New Drug Code for Marihuana Extract
Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids into Schedule I
Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids into Schedule I; Correction
Schedules of Controlled Substances: Placement of 5-Methoxy-N,N-Dimethyltryptamine into Schedule I of Controlled Substances Act
Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids into Schedule I
Schedules of Controlled Substances: Placement of Propofol into Schedule IV
Schedules of Controlled Substances: Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine into Schedule I of Controlled Substances Act; Correction
Schedules of Controlled Substances: Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine into Schedule I of Controlled Substances Act; Correction
Correction of Code of Federal Regulations: Removal of Temporary Listing of Benzylfentanyl and Thenylfentanyl as Controlled Substances
Control of Immediate Precursors Used in Illicit Manufacture of Fentanyl as Schedule II Controlled Substance
Schedules of Controlled Substances: Exempted Prescription Product; River Edge Pharmaceutical, Servira
Schedules of Controlled Substances: Placement of Carisoprodol into Schedule IV; Announcement of Hearing
Schedules of Controlled Substances; Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhalers Manufactured by Classic Pharmaceuticals, LLC
Schedules of Controlled Substances: Placement of Fospropofol into Schedule IV
Schedules of Controlled Substances: Placement of Lacosamide into Schedule V
Schedules of Controlled Substances: Placement of Tapentadol into Schedule II
Listing of Approved Drug Products Containing Dronabinol in Schedule III
Details Information
Comments
View AllSubmitter: Adkins, Sarah Posted: 11/08/2010 ID: DEA-2010-0023-0006
Jan 03,2011 11:59 PM ET
Submitter: Schoeffler, Linda Posted: 11/16/2010 ID: DEA-2010-0023-0007
Jan 03,2011 11:59 PM ET
Submitter: MITTEER, MARK Posted: 11/16/2010 ID: DEA-2010-0023-0008
Jan 03,2011 11:59 PM ET
Submitter: Rakoczy, William Posted: 12/02/2010 ID: DEA-2010-0023-0009
Jan 03,2011 11:59 PM ET
Submitter: Nexus, Lyme Posted: 12/02/2010 ID: DEA-2010-0023-0010
Jan 03,2011 11:59 PM ET
Related Documents
More